SuperworthStructure Therapeutics market cap GPCR
Share price times shares outstanding: what the whole company sells for, since 2023.
- Today, Oct 23, 2026
- $1.5B
- Highest close in our data
- $5.5B
- Jan 2026
Structure Therapeutics is worth $1.5B at the close on Oct 23, 2026, at $21.19 a share.
That is down 1% over the last year.
Its highest close in our data was $5.5B in Jan 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.5B | $1.5B | $5.5B | −64% |
| 2025 | $4.1B | $867M | $4.1B | +149% |
| 2024 | $1.7B | $1.6B | $2.5B | −12% |
| 2023 | $1.9B | $927.6M | $2.9B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Structure Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| GPCRStructure Therapeutics | $1.5B |
| ANABAnaptysbio | $1.5B |
| PCRXPacira BioSciences | $1.5B |
| PAHCPhibro Animal Health | $1.6B |
| ANIPANI Pharmaceuticals | $1.7B |
| OMEROmeros | $1.2B |
| HRMYHarmony Biosciences | $2.1B |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| PBHPrestige Consumer Healthcare | $2.3B |
| ABUSArbutus Biopharma | $831M |
| NRIXNurix Therapeutics | $2.8B |
| Peer median | $1.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Structure Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.